- Home
- MREO vs VKI Comparison
MREO vs VKI Comparison
Compare MREO & VKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- VKI
- Stock Information
- Founded
- MREO 2015
- VKI 1993
- Country
- MREO United Kingdom
- VKI United States
- Employees
- MREO N/A
- VKI N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- VKI Finance Companies
- Sector
- MREO Health Care
- VKI Finance
- Exchange
- MREO Nasdaq
- VKI Nasdaq
- Market Cap
- MREO 369.2M
- VKI 381.0M
- IPO Year
- MREO N/A
- VKI N/A
- Fundamental
- Price
- MREO $2.30
- VKI $8.22
- Analyst Decision
- MREO Strong Buy
- VKI
- Analyst Count
- MREO 7
- VKI 0
- Target Price
- MREO $7.71
- VKI N/A
- AVG Volume (30 Days)
- MREO 1.7M
- VKI 112.8K
- Earning Date
- MREO 05-14-2025
- VKI 01-01-0001
- Dividend Yield
- MREO N/A
- VKI 4.52%
- EPS Growth
- MREO N/A
- VKI N/A
- EPS
- MREO N/A
- VKI N/A
- Revenue
- MREO N/A
- VKI N/A
- Revenue This Year
- MREO N/A
- VKI N/A
- Revenue Next Year
- MREO $61.92
- VKI N/A
- P/E Ratio
- MREO N/A
- VKI N/A
- Revenue Growth
- MREO N/A
- VKI N/A
- 52 Week Low
- MREO $1.58
- VKI $7.07
- 52 Week High
- MREO $5.02
- VKI $8.98
- Technical
- Relative Strength Index (RSI)
- MREO 52.99
- VKI 40.74
- Support Level
- MREO $1.58
- VKI $8.16
- Resistance Level
- MREO $2.37
- VKI $8.35
- Average True Range (ATR)
- MREO 0.21
- VKI 0.18
- MACD
- MREO 0.04
- VKI -0.01
- Stochastic Oscillator
- MREO 91.19
- VKI 40.74
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About VKI Invesco Advantage Municipal Income Trust II of Beneficial Interest (DE)
Invesco Advantage Municipal Income Trust II is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.